Product NDC: | 0555-0768 |
Proprietary Name: | Adderall |
Non Proprietary Name: | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate |
Active Ingredient(s): | 7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1 & nbsp; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0768 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040422 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080811 |
Package NDC: | 0555-0768-02 |
Package Description: | 100 TABLET in 1 BOTTLE (0555-0768-02) |
NDC Code | 0555-0768-02 |
Proprietary Name | Adderall |
Package Description | 100 TABLET in 1 BOTTLE (0555-0768-02) |
Product NDC | 0555-0768 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080811 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
Strength Number | 7.5; 7.5; 7.5; 7.5 |
Strength Unit | mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |